1) N-((3α,7α,12α)-Trihydroxy-5β-cholan-24-oyl)taurine
牛黄胆酸
2) sodium taurocholate
牛黄胆酸钠
1.
(Methods)The SAP model was developed in rats by retrograde injection of 5% sodium taurocholate into biliopancreatic duct through duodenal wall.
方法46只健康雄性SD大鼠分为SAP组和对照组,SAP组经肠壁穿刺逆行胰胆管注射5%牛黄胆酸钠,对照组同法注射等量0。
2.
Objective:To develop an HPLC-ELSD method for simultaneous determination of cholic acid,deoxycholic acid and sodium taurocholate in Niudan powder(from Bos Taurus domesticus Gemelin).
目的:建立HPLC-ELSD同时测定动物类药材牛胆粉中胆酸、去氧胆酸和牛黄胆酸钠3种成分含量的方法。
3) Taurocholic acid/metab
牛黄胆酸/代谢
4) Cholic acid
牛胆酸
1.
The protective effect of cholic acid on an in vitro injury model of ischemia-reperfusion in cerebral microvascular endothelial cells;
脑微血管内皮细胞体外缺血再灌注模型的建立及牛胆酸的保护作用
5) taurocholic acid
牛磺胆酸
1.
Determination of taurocholic acid in Shedanchuanbei Oral Liquid and snake bile by SPE-HPLC;
蛇胆川贝液和蛇胆汁中牛磺胆酸的SPE-HPLC法测定
2.
To explore the effect of taurocholic acid (TCA) on thymocyte apoptosis, a flow cytometry was adopted to detect the effect of TCA on phosphatidylserine during the process of Apoptosis; the spectrophotometry was used to examine the effect of TCA on activity changes of caspase-9 and caspase-3.
探讨牛磺胆酸对小鼠胸腺细胞凋亡影响的机理。
3.
Objective To determine the content of the taurocholic acid in Shedanchuanbei solution by TLCS.
目的建立以薄层扫描法测定蛇胆川贝液中牛磺胆酸含量的方法。
6) sodium deoxycholate
牛磺胆酸
1.
5% sodium deoxycholate through retrogradely biliopancreatic ducts.
目的 探讨 3 5 %牛磺胆酸钠逆行胰胆管注射诱导重症急性胰腺炎大鼠模型的可行性及相关技术的改良。
补充资料：牛黄胆酸
分子式：C26H45NO7S
分子量：515.71
CAS号：81-24-3
性质：非结晶形粉末。 熔点125℃（分解），[α]20/D+38.8°（乙醇-水）。易吸湿。易溶于水，溶于乙醇，几乎不溶于乙醚、乙酸乙酯。遇酸碱分解成胆酸和牛磺酸。
制备方法：由动物器官中提取。
用途：去氢胆酸的中间体。LD50（大鼠）380mg/kg。
分子量：515.71
CAS号：81-24-3
性质：非结晶形粉末。 熔点125℃（分解），[α]20/D+38.8°（乙醇-水）。易吸湿。易溶于水，溶于乙醇，几乎不溶于乙醚、乙酸乙酯。遇酸碱分解成胆酸和牛磺酸。
制备方法：由动物器官中提取。
用途：去氢胆酸的中间体。LD50（大鼠）380mg/kg。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条